S. Res. 299 (119th)Bill Overview

A resolution expressing support for the designation of July 2025 as "National Sarcoma Awareness Month".

Simple ResolutionHealth|CancerCommemorative events and holidays
Cosponsors
Support
Republican
Introduced
Jun 24, 2025
Discussions
Bill Text
Current stageIntroduced

Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S3520; text: CR S3518)

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Simple ResolutionWhat this resolution actually does

This resolution expresses the Senate's support for designating July 2025 as National Sarcoma Awareness Month. It is a Senate simple resolution that does not create law or change federal programs, but states the Senate's view and encourages awareness. Its practical effect is symbolic: promoting education, outreach, and attention to sarcoma without binding government action.

This Senate resolution expresses support for designating July 2025 as "National Sarcoma Awareness Month." It cites basic facts about sarcoma (a rare cancer of bone and connective tissues), annual U.S. incidence and mortality estimates, the number of subtypes, the potential for misdiagnosis, typical treatment options, and the rationale that an awareness month could encourage proper diagnosis and treatment.

The resolution is a symbolic, non‑binding statement and does not appropriate funds or create new programs.

Passage5/100

By content alone, the measure is extremely likely to be adopted by a chamber as a nonbinding expression of support because it is narrow and uncontroversial. However, as a simple Senate resolution it is not the type of measure that becomes statute or an enacted law and does not require presidential signature; therefore its 'likelihood to become law' is near zero in practical terms even though its adoption by the originating chamber is very likely.

CredibilityAligned

Relative to its intended legislative type, this bill is a concise and well-structured commemorative resolution: it clearly defines the issue and justification and performs the limited legal function of expressing support for designating July 2025 as National Sarcoma Awareness Month. It does not create obligations, amend law, or authorize funding.

Contention5/100

All three personas support the symbolic designation, but differ on expectations for follow-up: liberals want funding and equity measures, centrists want evidence‑based, cost‑managed follow‑through, and conservatives want to limit federal spending and prioritize private/state action.

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
Likely helpedFederal agencies

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • Potential benefitIncreased public and clinician awareness could lead to earlier recognition and diagnosis of sarcoma, which may improve…
  • Potential benefitA formal awareness month may boost fundraising and philanthropic activity for sarcoma research and patient support orga…
  • Potential benefitHeightened attention could increase enrollment in clinical trials and registries, improving data collection and acceler…
Likely burdened
  • Potential burdenThe resolution is purely symbolic and does not provide funding or regulatory changes, so critics may argue it will have…
  • Federal agenciesExpectations created by the designation could lead to disappointment if awareness does not translate into measurable in…
  • Potential burdenNonprofit groups and health agencies may incur modest costs to plan and run awareness activities tied to the month (com…
03 · Why people split

Why the argument around this bill splits.

All three personas support the symbolic designation, but differ on expectations for follow-up: liberals want funding and equity measures, centrists want evidence‑based, cost‑managed follow‑through, and conservatives wan…
Progressive95%

A mainstream liberal would view this resolution positively as a noncontroversial step to spotlight a relatively neglected cancer.

They would welcome the emphasis on awareness, earlier diagnosis, and the reminder that sarcoma affects adults and children, but would note that the resolution is symbolic and does not guarantee resources for research, treatment access, or equity.

They would likely urge follow-up actions — such as targeted research funding, support for underserved patients, and attention to disparities in diagnosis and care.

Leans supportive
Centrist90%

A pragmatic centrist would see this as a modest, low‑cost, unifying measure that raises awareness about a rare but serious disease.

They would appreciate the nonbinding nature and the potential public health benefit, while wanting clarity that the resolution does not create unfunded mandates or commit federal dollars.

They would favor follow-through that is evidence‑based and cost‑effective, such as targeted education for clinicians and collaboration with existing public‑health programs.

Leans supportive
Conservative90%

A mainstream conservative would generally support a nonbinding resolution recognizing an awareness month for a serious health condition, viewing it as a compassionate, low‑cost gesture that respects private-sector and nonprofit advocacy efforts.

They would emphasize that the resolution does not expand federal authority or create spending, and may caution against using such symbolic acts as a substitute for patient-centered, market‑driven solutions.

They might also stress state and local responsibility and private charity involvement for follow-up services.

Leans supportive
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Still ahead

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood5/100

By content alone, the measure is extremely likely to be adopted by a chamber as a nonbinding expression of support because it is narrow and uncontroversial. However, as a simple Senate resolution it is not the type of measure that becomes statute or an enacted law and does not require presidential signature; therefore its 'likelihood to become law' is near zero in practical terms even though its adoption by the originating chamber is very likely.

Scope and complexity
24%
Scopenarrow
24%
Complexitylow
Why this could stall
  • Whether the sponsor intends single-chamber (simple) resolution only or seeks a concurrent resolution/legislative action that would involve the House; the bill text is a simple Senate resolution, which does not become law.
  • The bill contains no cost estimates or directives for agencies; if follow-on implementation or funded programs are later proposed, fiscal implications would need new analysis.
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

All three personas support the symbolic designation, but differ on expectations for follow-up: liberals want funding and equity measures, c…

By content alone, the measure is extremely likely to be adopted by a chamber as a nonbinding expression of support because it is narrow and…

Unlocked analysis

Relative to its intended legislative type, this bill is a concise and well-structured commemorative resolution: it clearly defines the issue and justification and performs the limited legal function of expressing suppor…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis